IMVT
Immunovant, Inc.
Company overview
- Market capitalization
- $6.92B
- Employees
- 315
- Latest publication
- 2026-09-29
About Immunovant, Inc.
Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.
Financial statements
Income Quarterly
| Metric | Q1 20272026-06-30 · USD | Q4 20262026-03-31 · USD | Q3 20262025-12-31 · USD | Q2 20262025-09-30 · USD | Q1 20262025-06-30 · USD | Q4 20252025-03-31 · USD | Q3 20252024-12-31 · USD | Q2 20252024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -153,224,000USD | -147,856,000USD | -110,635,000USD | -126,502,000USD | -120,613,000USD | -106,449,000USD | -111,122,000USD | -109,119,000USD |
| Total Revenue | — | 0USD | 0USD | 0USD | 0USD | 160,000USD | 0USD | 0USD |
| Research Development | — | 142,287,000USD | 98,924,000USD | 114,249,000USD | 101,200,000USD | 93,651,000USD | 94,520,000USD | 97,272,000USD |
| Selling General Administrative | — | 17,267,000USD | 15,438,000USD | 17,513,000USD | 26,024,000USD | 20,174,000USD | 19,782,000USD | 18,471,000USD |
| Total Operating Expenses | — | 159,554,000USD | 114,362,000USD | 131,762,000USD | 127,224,000USD | 113,825,000USD | 114,302,000USD | 115,743,000USD |
| Operating Income | — | -159,554,000USD | -114,362,000USD | -131,762,000USD | -127,224,000USD | -113,825,000USD | -114,302,000USD | -115,743,000USD |
| Interest Income | — | 8,056,000USD | 5,333,000USD | 5,604,000USD | 6,337,000USD | 6,888,000USD | 4,590,000USD | 6,073,000USD |
| Net Interest Income | — | 8,056,000USD | 5,333,000USD | 5,604,000USD | 6,337,000USD | 6,888,000USD | 4,590,000USD | 6,073,000USD |
| Income Before Tax | — | -150,700,000USD | -109,083,000USD | -125,908,000USD | -119,700,000USD | -105,866,000USD | -110,970,000USD | -109,041,000USD |
| Income Tax Expense | — | -2,844,000USD | 1,552,000USD | 594,000USD | 913,000USD | 583,000USD | 152,000USD | 78,000USD |
| Tax Provision | — | -2,844,000USD | 1,552,000USD | 594,000USD | 913,000USD | 583,000USD | 152,000USD | 78,000USD |
| Net Income From Continuing Ops | — | -147,856,000USD | -110,635,000USD | -126,502,000USD | -120,613,000USD | -106,449,000USD | -111,122,000USD | -109,119,000USD |
| Ebit | — | -159,554,000USD | -109,083,000USD | -131,762,000USD | -127,224,000USD | -113,825,000USD | -114,302,000USD | -115,743,000USD |
| Ebitda | — | -159,458,000USD | -108,982,000USD | -131,657,000USD | -127,117,000USD | -113,716,000USD | -114,203,000USD | -115,654,000USD |
| Depreciation And Amortization | — | 96,000USD | 101,000USD | 105,000USD | 107,000USD | 109,000USD | 99,000USD | 89,000USD |
| Reconciled Depreciation | — | 96,000USD | 101,000USD | 105,000USD | 107,000USD | 109,000USD | 99,000USD | 89,000USD |
| Total Other Income Expense Net | — | 8,854,000USD | 5,279,000USD | 5,854,000USD | 7,524,000USD | 7,959,000USD | 3,332,000USD | 6,702,000USD |
| Cost Of Revenue | — | — | 101,000USD | 105,000USD | 107,000USD | 80,000USD | 99,000USD | 89,000USD |
| Gross Profit | — | — | -101,000USD | -105,000USD | -107,000USD | 80,000USD | -99,000USD | -89,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | 80,000USD | — | — |
| Source | DisclosureVerified | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20262026-03-31 · USD | FY 20252025-03-31 · USD | FY 20242024-03-31 · USD | FY 20232023-03-31 · USD | FY 20222022-03-31 · USD | FY 20212021-03-31 · USD | FY 20202020-03-31 · USD | FY 20192018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Cost Of Revenue | 409,000USD | 377,000USD | 231,000USD | 1,324,000USD | 1,232,000USD | 998,000USD | 21,000USD | — |
| Gross Profit | -409,000USD | -377,000USD | -231,000USD | -1,324,000USD | -1,232,000USD | -998,000USD | -21,000USD | — |
| Research Development | 456,660,000USD | 360,917,000USD | 212,928,000USD | 160,257,000USD | 101,808,000USD | 68,604,000USD | 47,927,000USD | — |
| Selling General Administrative | 76,242,000USD | 77,235,000USD | 57,281,000USD | 48,019,000USD | 54,225,000USD | 39,513,000USD | 18,151,000USD | — |
| Total Operating Expenses | 532,902,000USD | 438,152,000USD | 270,209,000USD | 208,276,000USD | 156,033,000USD | 108,117,000USD | 59,657,000USD | — |
| Operating Income | -532,902,000USD | -438,152,000USD | -270,209,000USD | -208,276,000USD | -156,033,000USD | -108,117,000USD | -59,678,000USD | -450USD |
| Interest Income | 25,330,000USD | 24,732,000USD | 24,948,000USD | 7,578,000USD | 0USD | — | 625,000USD | — |
| Net Interest Income | 25,330,000USD | 24,732,000USD | 24,948,000USD | 7,578,000USD | 0USD | 0USD | -625,000USD | — |
| Income Before Tax | -505,391,000USD | -412,949,000USD | -258,769,000USD | -210,951,000USD | -156,814,000USD | -107,789,000USD | -66,291,000USD | -450USD |
| Income Tax Expense | 215,000USD | 891,000USD | 567,000USD | 9,000USD | -84,000USD | -358,000USD | 97,000USD | — |
| Tax Provision | 215,000USD | 891,000USD | 567,000USD | 9,000USD | -84,000USD | -358,000USD | 97,000USD | — |
| Net Income | -505,606,000USD | -413,840,000USD | -259,336,000USD | -210,960,000USD | -156,730,000USD | -107,431,000USD | -66,388,000USD | -450USD |
| Net Income From Continuing Ops | -505,606,000USD | -413,840,000USD | -259,336,000USD | -210,960,000USD | -156,730,000USD | -107,431,000USD | -66,388,000USD | — |
| Ebit | -532,902,000USD | -438,152,000USD | -270,209,000USD | -208,276,000USD | -156,033,000USD | -108,117,000USD | -65,666,000USD | — |
| Ebitda | -532,493,000USD | -437,775,000USD | -269,978,000USD | -208,083,000USD | -155,907,000USD | -108,052,000USD | -65,645,000USD | — |
| Depreciation And Amortization | 409,000USD | 377,000USD | 231,000USD | 193,000USD | 126,000USD | 65,000USD | 21,000USD | — |
| Reconciled Depreciation | 409,000USD | 377,000USD | 231,000USD | 193,000USD | 126,000USD | 65,000USD | 21,000USD | — |
| Total Other Income Expense Net | 27,511,000USD | 25,203,000USD | 11,440,000USD | -2,675,000USD | -781,000USD | 328,000USD | -6,613,000USD | — |
| Selling And Marketing Expenses | — | — | 231,000USD | — | — | — | — | — |
| Interest Expense | — | — | 49,896,000USD | 12,482,000USD | 655,000USD | 0USD | 625,000USD | 0USD |
| Non Operating Income Net Other | — | — | — | -253,000USD | -781,000USD | 328,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -210,960,000USD | -156,730,000USD | -107,431,000USD | -66,388,000USD | -450USD |
| Unclassified Operating Expenses | — | — | — | — | — | — | -6,421,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20272026-06-30 · USD | Q4 20262026-03-31 · USD | Q3 20262025-12-31 · USD | Q2 20262025-09-30 · USD | Q1 20262025-06-30 · USD | Q4 20252025-03-31 · USD | Q3 20252024-12-31 · USD | Q2 20252024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 852,490,000USD | 957,014,000USD | 1,052,392,000USD | 582,959,000USD | 661,440,000USD | 776,222,000USD | 420,932,000USD | 515,707,000USD |
| Cash And Equivalents | 797,798,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 851,178,000USD | 948,819,000USD | 1,042,939,000USD | 573,546,000USD | 651,763,000USD | 767,662,000USD | 412,541,000USD | 507,372,000USD |
| Other Non Current Assets | 961,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 117,102,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 117,102,000USD | 104,422,000USD | 66,257,000USD | 63,254,000USD | 52,900,000USD | 68,775,000USD | 68,315,000USD | 66,653,000USD |
| Total Stockholder Equity | 735,388,000USD | 852,592,000USD | 986,135,000USD | 519,705,000USD | 608,540,000USD | 707,447,000USD | 352,617,000USD | 449,054,000USD |
| Total Equity Including Noncontrolling Interest | 735,388,000USD | — | — | — | — | — | — | — |
| Net Receivables | 697,000USD | 3,946,000USD | 1,643,000USD | 1,970,000USD | 1,936,000USD | 2,511,000USD | 2,224,000USD | 1,876,000USD |
| Property Plant Equipment Net | 351,000USD | 515,000USD | 531,000USD | 632,000USD | 737,000USD | 942,000USD | 774,000USD | 716,000USD |
| Accounts Payable | 10,138,000USD | 7,541,000USD | 8,616,000USD | 6,916,000USD | 7,843,000USD | 17,656,000USD | 19,816,000USD | 20,727,000USD |
| Common Stock | 20,000USD | 20,000USD | 20,000USD | 17,000USD | 16,000USD | 16,000USD | 14,000USD | 14,000USD |
| Retained Earnings | -1,898,353,000USD | -1,745,129,000USD | -1,597,273,000USD | -1,486,638,000USD | -1,360,136,000USD | -1,239,523,000USD | -1,133,074,000USD | -1,021,952,000USD |
| Accumulated Other Comprehensive Income | 725,000USD | 730,000USD | 1,197,000USD | 1,450,000USD | 1,737,000USD | 1,459,000USD | 2,479,000USD | 1,910,000USD |
| Other Current Assets | — | 42,763,000USD | 46,771,000USD | 49,706,000USD | 50,915,000USD | 51,180,000USD | 35,632,000USD | 32,555,000USD |
| Total Liab | — | 104,422,000USD | 66,257,000USD | 63,254,000USD | 52,900,000USD | 68,775,000USD | 68,315,000USD | 66,653,000USD |
| Other Current Liab | — | 96,809,000USD | 57,641,000USD | 56,338,000USD | 45,057,000USD | 51,021,000USD | 48,476,000USD | 45,879,000USD |
| Capital Stock | — | 20,000USD | 20,000USD | 17,000USD | 16,000USD | 16,000USD | 14,000USD | 14,000USD |
| Cash | — | 902,110,000USD | 994,525,000USD | 521,870,000USD | 598,912,000USD | 713,971,000USD | 374,685,000USD | 472,941,000USD |
| Cash And Short Term Investments | — | 902,110,000USD | 994,525,000USD | 521,870,000USD | 598,912,000USD | 713,971,000USD | 374,685,000USD | 472,941,000USD |
| Net Debt | — | -902,038,000USD | -994,525,000USD | -521,870,000USD | -598,912,000USD | -713,873,000USD | -374,662,000USD | -472,894,000USD |
| Short Term Debt | — | 72,000USD | — | — | — | 98,000USD | 23,000USD | 47,000USD |
| Short Long Term Debt Total | — | 72,000USD | — | — | — | 98,000USD | 23,000USD | 47,000USD |
| Property Plant Equipment Gross | — | 515,000USD | — | — | — | 942,000USD | 774,000USD | 716,000USD |
| Common Stock Shares Outstanding | — | 203,709,320shares | 181,513,386shares | 173,643,829shares | 170,872,994shares | 151,574,000shares | 146,922,000shares | 146,469,000shares |
| Non Current Assets Total | — | 8,195,000USD | 9,453,000USD | 9,413,000USD | 9,677,000USD | 8,560,000USD | 8,391,000USD | 8,335,000USD |
| Non Current Liabilities Total | — | 0USD | 0USD | 0USD | 0USD | 1,097,999USD | 0USD | 0USD |
| Non Currrent Assets Other | — | 7,680,000USD | 8,922,000USD | 8,781,000USD | 8,940,000USD | 7,618,000USD | 7,617,000USD | 7,619,000USD |
| Net Working Capital | — | 844,397,000USD | 976,682,000USD | 510,292,000USD | 598,863,000USD | 698,887,000USD | 344,226,000USD | 440,719,000USD |
| Unclassified Equity | — | 2,596,951,000USD | 2,582,171,000USD | 2,004,859,000USD | 1,966,907,000USD | 1,945,479,000USD | 1,483,184,000USD | 1,469,068,000USD |
| Unclassified Non Current Liabilities | — | — | — | — | — | 1,097,999USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20262026-03-31 · USD | FY 20252025-03-31 · USD | FY 20242024-03-31 · USD | FY 20232023-03-31 · USD | FY 20222022-03-31 · USD | FY 20212021-03-31 · USD | FY 20202020-03-31 · USD | FY 20192019-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 957,567,000USD | 776,222,000USD | 666,712,000USD | 405,838,000USD | 515,564,000USD | 412,489,000USD | 109,387,000USD | 405,000USD |
| Other Current Assets | 42,763,000USD | 51,180,000USD | 24,902,000USD | 26,916,000USD | 6,253,000USD | 7,716,000USD | 5,460,000USD | 5,594USD |
| Total Liab | 104,975,000USD | 68,775,000USD | 48,955,000USD | 43,344,000USD | 45,739,000USD | 21,009,000USD | 15,318,000USD | 380,448USD |
| Total Stockholder Equity | 852,592,000USD | 707,447,000USD | 617,757,000USD | 362,494,000USD | 469,825,000USD | 391,480,000USD | 94,069,000USD | 24,552USD |
| Other Current Liab | 96,809,000USD | 51,021,000USD | 41,315,000USD | 40,771,000USD | 24,746,000USD | 15,160,000USD | 10,938,000USD | 80,242USD |
| Common Stock | 20,000USD | 16,000USD | 14,000USD | 13,000USD | 12,000USD | 10,000USD | 5,000USD | 288USD |
| Capital Stock | 20,000USD | 16,000USD | 14,000USD | 13,000USD | 12,000USD | 10,000USD | 5,000USD | 288USD |
| Retained Earnings | -1,745,129,000USD | -1,239,523,000USD | -825,683,000USD | -566,347,000USD | -355,387,000USD | -198,657,000USD | -91,226,000USD | -448USD |
| Cash | 902,110,000USD | 713,971,000USD | 635,365,000USD | 376,532,000USD | 493,817,000USD | 400,146,000USD | 100,571,000USD | 325,000USD |
| Cash And Short Term Investments | 902,110,000USD | 713,971,000USD | 635,365,000USD | 376,532,000USD | 493,817,000USD | 400,146,000USD | 100,571,000USD | 325,000USD |
| Total Current Assets | 948,819,000USD | 767,662,000USD | 665,770,000USD | 404,333,000USD | 512,931,000USD | 409,006,000USD | 109,076,000USD | 325,000USD |
| Total Current Liabilities | 104,422,000USD | 68,775,000USD | 48,608,000USD | 43,297,000USD | 44,520,000USD | 18,771,000USD | 15,318,000USD | 380,448USD |
| Net Debt | -902,038,000USD | -713,873,000USD | -635,227,000USD | -375,312,000USD | -491,453,000USD | -396,729,000USD | -97,381,000USD | -25,000USD |
| Short Term Debt | 72,000USD | 98,000USD | 138,000USD | 1,173,000USD | 1,145,000USD | 1,179,000USD | 3,190,000USD | 300,000USD |
| Short Long Term Debt Total | 72,000USD | 98,000USD | 138,000USD | 1,220,000USD | 2,364,000USD | 3,417,000USD | 3,190,000USD | 300,000USD |
| Net Receivables | 3,946,000USD | 2,511,000USD | 5,503,000USD | 885,000USD | 12,861,000USD | 1,144,000USD | 3,045,000USD | 2,962,000USD |
| Accounts Payable | 7,541,000USD | 17,656,000USD | 7,155,000USD | 1,353,000USD | 18,629,000USD | 2,432,000USD | 1,190,000USD | 206USD |
| Property Plant Equipment Net | 515,000USD | 942,000USD | 595,000USD | 1,505,000USD | 2,633,000USD | 3,483,000USD | 65,000USD | 54USD |
| Property Plant Equipment Gross | 515,000USD | 942,000USD | 595,000USD | 1,505,000USD | 2,633,000USD | 3,483,000USD | 65,000USD | — |
| Accumulated Other Comprehensive Income | 730,000USD | 1,459,000USD | 1,908,000USD | 852,000USD | 404,000USD | -298,000USD | -16,000USD | 343,000USD |
| Common Stock Shares Outstanding | 182,421,233shares | 151,574,000shares | 138,100,000shares | 123,075,329shares | 109,679,256shares | 87,756,513shares | 43,199,191shares | 14,375,000shares |
| Non Current Assets Total | 8,748,000USD | 8,560,000USD | 942,000USD | 1,505,000USD | 2,633,000USD | 3,483,000USD | 311,000USD | 80,000USD |
| Non Current Liabilities Total | 552,999USD | 1,097,999USD | 347,000USD | 47,000USD | 1,219,000USD | 2,238,000USD | 14,128,000USD | 300,000USD |
| Non Currrent Assets Other | 7,680,000USD | 7,618,000USD | — | — | — | — | 246,000USD | 79,946USD |
| Net Working Capital | 844,397,000USD | 698,887,000USD | 617,162,000USD | 361,036,000USD | 468,411,000USD | 390,235,000USD | 93,758,000USD | -55,448USD |
| Unclassified Equity | 2,596,951,000USD | 1,945,479,000USD | 1,441,504,000USD | 927,963,000USD | 824,784,000USD | 590,415,000USD | 185,301,000USD | — |
| Unclassified Non Current Liabilities | — | 1,097,999USD | — | — | — | — | 13,882,000USD | — |
| Current Deferred Revenue | — | — | -26,709,000USD | — | — | — | -3,190,000USD | -206USD |
| Inventory | — | — | -24,902,000USD | 0USD | 0USD | 0USD | — | — |
| Non Current Liabilities Other | — | — | — | 47,000USD | 1,219,000USD | 2,238,000USD | — | — |
| Net Tangible Assets | — | — | — | 362,494,000USD | 469,825,000USD | 391,480,000USD | 94,069,000USD | 7,339,000USD |
| Deferred Long Term Liab | — | — | — | — | — | — | 246,000USD | 1,195,000USD |
| Other Assets | — | — | — | — | — | — | 246,000USD | 0USD |
| Short Long Term Debt | — | — | — | — | — | — | — | 300,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | — | -2,967,594USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20272026-06-30 · USD | Q4 20262026-03-31 · USD | Q3 20262025-12-31 · USD | Q2 20262025-09-30 · USD | Q1 20262025-06-30 · USD | Q4 20252025-03-31 · USD | Q3 20252024-12-31 · USD | Q2 20252024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 92,000USD | 96,000USD | 101,000USD | 105,000USD | 107,000USD | 109,000USD | 99,000USD | 89,000USD |
| Stock Based Compensation | 13,774,000USD | 11,141,000USD | 12,715,000USD | 13,358,000USD | 18,510,000USD | 11,687,000USD | 11,652,000USD | 12,693,000USD |
| Change To Account Receivables | 436,000USD | -1,823,000USD | 319,000USD | -25,000USD | 129,000USD | -176,000USD | -197,000USD | 417,000USD |
| Change In Working Capital | 7,199,000USD | 41,534,000USD | 5,469,000USD | 10,500,000USD | -15,439,000USD | -16,006,000USD | -1,043,000USD | 7,668,000USD |
| Operating Cash Flow | -124,405,000USD | — | — | — | — | — | — | — |
| Financing Cash Flow | 20,097,000USD | — | — | — | — | — | — | — |
| Effect Of Forex Changes On Cash | -4,000USD | — | — | — | — | — | — | — |
| Change In Cash | -104,312,000USD | -92,415,000USD | 472,655,000USD | -77,042,000USD | -115,059,000USD | 339,286,000USD | -98,256,000USD | -87,064,000USD |
| End Cash Flow | 797,798,000USD | — | — | — | — | — | — | — |
| Net Income | — | -147,856,000USD | -110,635,000USD | -126,502,000USD | -120,613,000USD | -106,449,000USD | -111,122,000USD | -109,119,000USD |
| Other Non Cash Items | — | 26,000USD | 25,000USD | 24,000USD | 24,000USD | 22,000USD | 23,000USD | 22,000USD |
| Total Cash From Operating Activities | — | -95,059,000USD | -92,325,000USD | -102,515,000USD | -117,411,000USD | -110,637,000USD | -100,391,000USD | -88,647,000USD |
| Capital Expenditures | — | -8,000USD | 0USD | 0USD | 0USD | -201,000USD | -180,000USD | -196,000USD |
| Free Cash Flow | — | -95,067,000USD | -92,325,000USD | -102,515,000USD | -117,411,000USD | -110,838,000USD | -100,571,000USD | -88,843,000USD |
| Total Cashflows From Investing Activities | — | -8,000USD | — | — | — | -201,000USD | -180,000USD | -196,000USD |
| Total Cash From Financing Activities | — | 3,640,000USD | 564,603,000USD | 24,595,000USD | 2,918,000USD | 450,612,000USD | 2,464,000USD | 730,000USD |
| Issuance Of Capital Stock | — | 0USD | — | — | — | 450,000,000USD | — | — |
| Begin Period Cash Flow | — | 994,525,000USD | 521,870,000USD | 598,912,000USD | 713,971,000USD | 374,685,000USD | 472,941,000USD | 560,005,000USD |
| End Period Cash Flow | — | 902,110,000USD | 994,525,000USD | 521,870,000USD | 598,912,000USD | 713,971,000USD | 374,685,000USD | 472,941,000USD |
| Other Cashflows From Financing Activities | — | 82,000USD | — | 24,595,000USD | — | 612,000USD | 2,464,000USD | 730,000USD |
| Unclassified Financing Cash Flow | — | 3,558,000USD | — | — | — | — | — | — |
| Investments | — | — | — | 0USD | 0USD | -201,000USD | -180,000USD | -196,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20262026-03-31 · USD | FY 20252025-03-31 · USD | FY 20242024-03-31 · USD | FY 20232023-03-31 · USD | FY 20222022-03-31 · USD | FY 20212021-03-31 · USD | FY 20202020-03-31 · USD | FY 20192018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -505,606,000USD | -413,840,000USD | -259,336,000USD | -210,960,000USD | -156,730,000USD | -107,431,000USD | -66,388,000USD | -450USD |
| Depreciation | 409,000USD | 377,000USD | 231,000USD | 193,000USD | 126,000USD | 998,000USD | 21,000USD | — |
| Stock Based Compensation | 55,724,000USD | 49,487,000USD | 41,116,000USD | 32,296,000USD | 34,244,000USD | 18,822,000USD | 6,963,000USD | — |
| Other Non Cash Items | 99,000USD | 133,000USD | 1,130,000USD | 1,131,000USD | 1,106,000USD | 18,540,000USD | 1,241,000USD | — |
| Change To Account Receivables | -1,400,000USD | 2,971,000USD | -4,558,000USD | 12,225,000USD | -11,718,000USD | 2,497,000USD | -83,000USD | — |
| Change In Working Capital | 42,064,000USD | -12,031,000USD | 2,632,000USD | -10,853,000USD | 15,142,000USD | 4,566,000USD | 4,806,000USD | — |
| Total Cash From Operating Activities | -407,310,000USD | -375,874,000USD | -214,227,000USD | -188,193,000USD | -106,112,000USD | -83,327,000USD | -53,357,000USD | — |
| Capital Expenditures | -8,000USD | -759,000USD | -360,000USD | -197,000USD | -254,000USD | -210,000USD | -31,000USD | 0USD |
| Free Cash Flow | -407,318,000USD | -376,633,000USD | -214,587,000USD | -188,390,000USD | -106,366,000USD | -83,537,000USD | -53,388,000USD | — |
| Total Cashflows From Investing Activities | -8,000USD | -759,000USD | -360,000USD | -197,000USD | -254,000USD | -210,000USD | -31,000USD | — |
| Total Cash From Financing Activities | 595,756,000USD | 454,492,000USD | 472,427,000USD | 70,885,000USD | 200,129,000USD | 383,112,000USD | 146,974,000USD | 325,000USD |
| Issuance Of Capital Stock | 544,194,000USD | 450,000,000USD | 472,745,000USD | 70,500,000USD | 0USD | 319,783,000USD | 0USD | — |
| Change In Cash | 188,139,000USD | 78,606,000USD | 258,833,000USD | -117,285,000USD | 93,671,000USD | 299,575,000USD | 93,586,000USD | 325,000USD |
| Begin Period Cash Flow | 713,971,000USD | 635,365,000USD | 376,532,000USD | 493,817,000USD | 400,146,000USD | 100,571,000USD | 6,985,000USD | — |
| End Period Cash Flow | 902,110,000USD | 713,971,000USD | 635,365,000USD | 376,532,000USD | 493,817,000USD | 400,146,000USD | 100,571,000USD | — |
| Other Cashflows From Financing Activities | -504,000USD | 4,492,000USD | -318,000USD | 385,000USD | 200,129,000USD | 383,112,000USD | 109,067,000USD | — |
| Unclassified Financing Cash Flow | 52,066,000USD | — | — | — | -200,000,000USD | -382,016,000USD | — | — |
| Investments | — | -759,000USD | -360,000USD | -197,000USD | -254,000USD | -210,000USD | -31,000USD | — |
| Change To Liabilities | — | — | — | -1,400,000USD | 25,902,000USD | 5,719,000USD | 967,000USD | — |
| Sale Purchase Of Stock | — | — | — | 70,885,000USD | 200,000,000USD | 385,206,000USD | 1,000USD | 25,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -117,505,000USD | 93,763,000USD | 299,575,000USD | — | — |
| Net Borrowings | — | — | — | — | 0USD | -3,190,000USD | 37,907,000USD | — |
| Change To Inventory | — | — | — | — | — | 596,000USD | 83,000USD | — |
| Unclassified Operating Cash Flow | — | — | — | — | — | -18,822,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.